subject expert committee

Subject Expert Committee Okays AstraZeneca, Bharat Biotech Vaccine Pitches

India Approves Two Vaccine Candidates, But Let’s Not Pretend Everything Is Okay

Serum Institute, Bharat Biotech Vaccine Candidates Emergency Okay Paused

The panel had also suggested that the company pay compensation of around Rs 20 lakh to the affected patients.. Credit: Reuters/File Photo

J&J Can Sell TB Drug to Minors After Govt Panel Waives Local Trials